Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

201
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
201
Study Design in Statistics01:15

Study Design in Statistics

8.2K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.2K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

154
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
154
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

394
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
394
Experimental Designs01:16

Experimental Designs

11.5K
An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...
11.5K
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

450
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
450

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Orientational Switching as an Extra Degree of Freedom in Self-Assembled C<sub>70</sub> and Octanethiol on Au(111).

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Super-resolution multimodal spatial transcriptomics reveals an ovoid stem cell niche structuring de novo shoot regeneration.

Molecular plant·2026
Same author

Laminar patterning transcription factors orchestrate spatial metabolite partitioning in Capsicum fruit.

Nature plants·2026
Same author

Rationale for incorporating short-term endpoints in interim futility analysis of phase 3 oncology trials: a simulation study.

BMC medical research methodology·2026
Same author

Unnoticed Entry, Noticed Transmission: Epidemiological Insights into China's First clade Ib MPXV cluster.

The Journal of infectious diseases·2026
Same author

Mechanical Strength: An Unrecognised Target in the Genetic Improvement of Crops.

Plant biotechnology journal·2026

Related Experiment Video

Updated: Jul 12, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K

Group sequential design with maximin efficiency robust test for immunotherapy with generalized delayed treatment

Bosheng Li1, Jingyi Zhang1, Wenyun Yang1

  • 1Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Nanjing, China.

Pharmaceutical Statistics
|October 20, 2023
PubMed
Summary

This study introduces a flexible delayed treatment effect function and a robust statistical method for immunotherapy trials. The approach improves power and reduces sample size, offering economic benefits.

Keywords:
general lag modelgroup sequential boundariesmaximum sample sizestatistical powertype 1 error rate

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.7K

Related Experiment Videos

Last Updated: Jul 12, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.7K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Immunotherapy

Background:

  • Delayed treatment effects are common in immunotherapy, potentially causing power loss in group sequential trials.
  • Existing methods may not adequately address the variability and gradual onset of these effects.

Purpose of the Study:

  • To propose a generalized delayed treatment effect function for precise and flexible modeling.
  • To develop robust statistical methods for group sequential trials accounting for delayed effects.
  • To reduce power loss and optimize sample size estimation in immunotherapy trials.

Main Methods:

  • Developed a generalized delayed treatment effect function.
  • Employed the maximin efficiency robust test for enhanced power robustness.
  • Utilized Markov chain methods for group sequential boundary determination and power function calculation.
  • Applied iterative regressions for maximum sample size estimation.

Main Results:

  • Validated the effectiveness of proposed methods through extensive simulations, especially in balanced trials.
  • Demonstrated the accuracy of group sequential boundary calculations and maximum sample size estimations.
  • Showed significantly reduced maximum sample sizes compared to traditional log-rank tests in a real trial example.

Conclusions:

  • The proposed generalized delayed treatment effect function and robust statistical methods effectively address delayed treatment effects in immunotherapy.
  • The novel approaches enhance statistical power and lead to more accurate and economical sample size estimations.
  • This methodology offers a significant economic advantage for conducting clinical trials in immunotherapy.